• Publications
  • Influence
Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial
BackgroundUltrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on syntheticExpand